Kenvue Inc. (NYSE:KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s recent management change. He remarked:
“Consider Kenvue. Two years ago, this company was spun off by Johnson & Johnson, which just wanted to unload its fantastic consumer business… The company picked this fellow, Thibaut Mongon, and he’s the leader of, he was the leader of J&J’s Consumer Health division… We learned today that he was sacked after activist pressure, and Kirk Perry, a current director, was named interim CEO. Kenvue also announced a strategic review… That’s what we’re hoping will happen at Kraft Heinz.
Is this shocking? Was it amazing that Kenvue already got rid of the CEO in two years? Well, yes, if you saw the numbers. Kenvue reported minus 4% organic growth, and Wall Street was expecting plus 2 to 4%. But I bring this up because more deals are coming in that space… I’m extremely confident that someone will want some of Kenvue, if not all of Kenvue, because those brands grow slowly, but if you put a bunch of them together, you might have something that Wall Street gets very excited about.”
A pharmacist at a local store, stocking shelves with products from the consumer health company.
Kenvue Inc. develops and markets consumer health products across self-care, skin health, and essential health categories.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
